Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults

BACKGROUND: Rilpivirine (RPV), a recently developed, once daily HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), is not currently approved for pediatric patients, but is sometimes prescribed for adolescents with multiple treatment failures, for regimen simplification or to minimize toxici...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pediatr Infect Dis J
Asıl Yazarlar: Foca, Marc, Yogev, Ram, Wiznia, Andrew, Hazra, Rohan, Jean-Philippe, Patrick, Graham, Bobbie, Britto, Paula, Carey, Vincent J., King, Jennifer, Acosta, Edward P., Cressey, Tim R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5245132/
https://ncbi.nlm.nih.gov/pubmed/27187753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001214
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller